Antoinette Wozniak, MD, FACP, FASCO, discusses optimizing the use of immunotherapy in patients with non–small cell lung cancer. EP: 1.Dr. Giaccone on Treatment Options in NSCLC EP: 2.Dr. Rizvi on Biomarkers of Response to Immunotherapy in NSCLC EP: 3.Dr. West on the Use of Nivolumab...
Alexander Spira, MD, PhD, FACP, discusses the efficacy of mobocertinib in metastatic non–small cell lung cancer that harbors EGFR exon 20 insertion mutations. EP: 1.Mobocertinib Shows Encouraging ORR in EGFR Exon 20–Mutant Advanced NSCLC EP: 2.Dr. Fidler on the Potential U...
Nagy et al., “Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells”, Nat Med. 2002;8:801-807. Nervi et al., “Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID ...
BMC Med. 2014, 12, 236. [CrossRef] 49. Shojaei, E.; Rexachs, D.; Wong, A.; Epelde, F.; Luque, E. A Method for Projections of the Emergency Department Behaviour by Non-Communicable Diseases From 2019 to 2039. IEEE J. Biomed. Health Inform. 2020, 24, 2490–2498. [CrossRef] ...